Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 17;17(20):7560.
doi: 10.3390/ijerph17207560.

Time between Symptom Onset, Hospitalisation and Recovery or Death: Statistical Analysis of Belgian COVID-19 Patients

Collaborators, Affiliations

Time between Symptom Onset, Hospitalisation and Recovery or Death: Statistical Analysis of Belgian COVID-19 Patients

Christel Faes et al. Int J Environ Res Public Health. .

Abstract

There are different patterns in the COVID-19 outbreak in the general population and amongst nursing home patients. We investigate the time from symptom onset to diagnosis and hospitalization or the length of stay (LoS) in the hospital, and whether there are differences in the population. Sciensano collected information on 14,618 hospitalized patients with COVID-19 admissions from 114 Belgian hospitals between 14 March and 12 June 2020. The distributions of different event times for different patient groups are estimated accounting for interval censoring and right truncation of the time intervals. The time between symptom onset and hospitalization or diagnosis are similar, with median length between symptom onset and hospitalization ranging between 3 and 10.4 days, depending on the age of the patient (longest delay in age group 20-60 years) and whether or not the patient lives in a nursing home (additional 2 days for patients from nursing home). The median LoS in hospital varies between 3 and 10.4 days, with the LoS increasing with age. The hospital LoS for patients that recover is shorter for patients living in a nursing home, but the time to death is longer for these patients. Over the course of the first wave, the LoS has decreased.

Keywords: COVID-19; length of stay in hospital; symptom onset to hospitalization; truncation and interval-censoring.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure A1
Figure A1
Flow diagram: (n1; n2) on the left hand side correspond, respectively, to the number of patients for the analysis of time of symptom onset to hospitalization and for time of symptom onset to diagnosis. The number of patients n3 on the right hand size correspond to the length of stay in hospital.
Figure A2
Figure A2
Observed number of new hospitalization in the national surveillance survey (black) and reported number of confirmed hospitalizations in the population (red).
Figure A3
Figure A3
Observed density (proportion of the population in the survey) of time between symptom onset and hospitalization (top left) and between symptom onset and diagnosis (top right); and observed length of stay in hospital (all COVID-19 patients (middle left), recovered patients (middle right), patients that died (bottom left) and length of stay in ICU (bottom right).
Figure A3
Figure A3
Observed density (proportion of the population in the survey) of time between symptom onset and hospitalization (top left) and between symptom onset and diagnosis (top right); and observed length of stay in hospital (all COVID-19 patients (middle left), recovered patients (middle right), patients that died (bottom left) and length of stay in ICU (bottom right).
Figure A4
Figure A4
Comparison of delay distribution for different time periods. The boxplots show the estimated 5%,25%,50%,75% and 95% quantiles, based on Weibull regression. Results are based on the time period 01 March to 20 March (period 1), 21 March to 30 March (period 2), 31 March to 18 April (period 3) and 19 April to 12 June (period 4).
Figure A5
Figure A5
Comparison of delay distribution for different population groups. The boxplots show the estimated 5%,25%,50%,75% and 95% quantiles, based on (untruncated) Weibull regression. Results are based on period 21 March to 30 March.
Figure A6
Figure A6
Comparison of delay distribution for different population groups. The boxplots show the estimated 5%,25%,50%,75% and 95% quantiles, based on a truncated Weibull regression. The time intervals are assumed interval-censored in intervals (xi1,xi+1). Results are based on period 21 March to 30 March.
Figure A7
Figure A7
Comparison of delay distribution for different population groups. The boxplots show the estimated 5%,25%,50%,75% and 95% quantiles, based on Weibull regression. Results are based on the time period 01 March to 20 March (period 1), 21 March to 30 March (period 2), 31 March to 18 April (period 3) and 19 April to 12 June (period 4).
Figure A8
Figure A8
Comparison of delay distribution for different population groups. The boxplots show the estimated 5%,25%,50%,75% and 95% quantiles, based on lognormal regression. The time intervals are assumed interval-censored in intervals (xi1,xi+1). Results are based on period 21 March to 30 March.
Figure 1
Figure 1
Comparison of delay distribution for different population groups. Top: delay from symptom onset to hospitalization and diagnosis; Middle: LoS for all patients and for recovered patients; Bottom: LoS for patients that died and LoS in ICU. The boxplots show the estimated 5%,25%,50%,75% and 95% quantiles. Results are based on period 21 March to 30 March. The reported values correspond to the 50%(25%,75%) quantiles.

References

    1. Vekaria B., Overton C.E., Wisniowski A., Ahmad S.H., Aparicio-Castro A., Curran-Sebastian J., Eddleston J., Hanley N.A., House T., Kim J., et al. Hospital length of stay for COVID-19 patients: Data-driven methods for forward planning. MedRXiv. 2020 doi: 10.21203/rs.3.rs-56855/v1. - DOI - PMC - PubMed
    1. Donnely C.A., Ghani A.C., Leung G.M., Hedley A.J., Fraser C., Riley S., Abu-Raddad L.J., Ho L.M., Thach T.Q., Chau P. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrom in Hong Kong. Lancet. 2003;361:1761–1766. doi: 10.1016/S0140-6736(03)13410-1. - DOI - PMC - PubMed
    1. Van Goethem N., Vilain A., Wyndham-Thomas C., Deblonde J., Bossuyt N., Rebolledo J., Lernout T., Quoilin S., Melis V., Van Beckhoven D. Rapid establishment of a national surveillance of COVID-19 hospitalizations in Belgium. Arch. Public Health. 2020:submitted. - PMC - PubMed
    1. Held L., Hens N., O’Neill P., Wallinga J. Handbook of Infectious Diseases Data Analysis. Chapman & Hall/CRC; Boca Raton, FL, USA: 2020.
    1. Hens N., Calatayud L., Kurkela S., Tamme T., Wallinga J. Robust reconstruction and analysis of outbreak data: Influenza A (H1N1)v transmission in a school-based population. Am. J. Epidemiol. 2012;24:224–250. doi: 10.1093/aje/kws006. - DOI - PubMed

Publication types

LinkOut - more resources